Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The neuropeptide S receptor 1 pseudogene (ENSG00000250756) is a non-functional genomic element and not a protein-coding gene. It does not encode a receptor, is not a therapeutic target, and has no reported biological or disease functions. The therapeutically relevant molecule is neuropeptide S receptor 1 (NPSR1), a G protein-coupled receptor implicated in asthma, inflammation, anxiety, and gastrointestinal function. NPSR1 mediates its effects via binding neuropeptide S, leading to downstream signal transduction through phospholipase C and adenylyl cyclase pathways with roles in intracellular calcium mobilization and cAMP formation. NPSR1 is the target for research, not the pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuropeptide S receptor 1 pseudogene.